evodiamine has been researched along with Small Cell Lung Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, X; Li, N; Liu, H; Qi, D; Wang, T; Zhang, J; Zhang, X; Zhong, C | 1 |
| Fan, X; Fang, C; Liu, L; Luo, J; Qi, D; Tan, Q; Zhang, J | 1 |
2 other study(ies) available for evodiamine and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
A novel evodiamine amino derivative as a PI3K/AKT signaling pathway modulator that induces apoptosis in small cell lung cancer cells.
Topics: Administration, Oral; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Male; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Signal Transduction; Small Cell Lung Carcinoma | 2021 |
Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum; Humans; Lung Neoplasms; M Phase Cell Cycle Checkpoints; Mitochondria; Quinazolines; Small Cell Lung Carcinoma | 2014 |